AHR and inflammatory bowel disease: Meanwhile, high expression of PU.1 for Th9 cells and AHR for Th22 cells were found to be important pathogenic regulators of IBD progression in recent years, yet therapeutic methods to target Th9 and Th22 cells are still preliminary.